Overview
This study aim to investigate the association between plasma NT-proBNP levels and the presence, extent and severity of stenosis in patients with suspected coronary artery disease.
Description
The investigators prospectively measured plasma NT-proBNP levels in consecutive patients referred to the center for elective diagnostic coronary angiography due to symptoms or signs of coronary artery disease over a two- year period. Patients with conditions known to elevate NT-proBNP levels, including heart failure, severe valvular disease, atrial fibrillation, severe chronic kidney disease (eGFR < 30 mL/min), prior coronary artery bypass grafting, or age over 80 years, were excluded.
Eligibility
Inclusion Criteria:
- patient referred for elective coronary angiography due to suspected CAD.
- NT-proBNP measurement during hospitalization
Exclusion Criteria:
- heart failure
- severe valvular disease
- atrial fibrillation
- severe chronic kidney disease (eGFR < 30 mL/min)
- prior coronary artery bypass grafting
- age over 80 years